GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) » Definitions » Accounts Payable

Cabio Biotech (Wuhan) Co (SHSE:688089) Accounts Payable : ¥62.1 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cabio Biotech (Wuhan) Co Accounts Payable?

Cabio Biotech (Wuhan) Co's Accounts Payable for the quarter that ended in Dec. 2024 was ¥62.1 Mil.

Cabio Biotech (Wuhan) Co's quarterly Accounts Payable increased from Jun. 2024 (¥70.1 Mil) to Sep. 2024 (¥79.9 Mil) but then declined from Sep. 2024 (¥79.9 Mil) to Dec. 2024 (¥62.1 Mil).

Cabio Biotech (Wuhan) Co's annual Accounts Payable declined from Dec. 2022 (¥107.3 Mil) to Dec. 2023 (¥70.9 Mil) and declined from Dec. 2023 (¥70.9 Mil) to Dec. 2024 (¥62.1 Mil).


Cabio Biotech (Wuhan) Co Accounts Payable Historical Data

The historical data trend for Cabio Biotech (Wuhan) Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cabio Biotech (Wuhan) Co Accounts Payable Chart

Cabio Biotech (Wuhan) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.53 31.43 107.34 70.86 62.07

Cabio Biotech (Wuhan) Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.86 63.97 70.11 79.90 62.07

Cabio Biotech (Wuhan) Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Cabio Biotech (Wuhan) Co Accounts Payable Related Terms

Thank you for viewing the detailed overview of Cabio Biotech (Wuhan) Co's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Cabio Biotech (Wuhan) Co Business Description

Traded in Other Exchanges
N/A
Address
No. 999, Gaoxin Avenue, East Lake New Technology Development Zone, Hubei Province, Wuhan, CHN, 430075
Cabio Biotech (Wuhan) Co Ltd is a biotechnology company, engaged in Research & Development, production and sales of polyunsaturated fatty acids ARA, algae oil DHA and SA, natural B-carotene and other series products. The products are used in infant formula, dietary nutrition supplements and health Food, special medical formula food and other fields. The company's product sales area covers China, the United States, Europe, Australia, New Zealand, South Korea, and Southeast Asia.
Executives
Shang Yun Core technical personnel
Xiao Min senior management
Wang Hua Biao Directors, senior managers
Geng An Feng senior management
Du Bin Director
Yi Hua Rong senior management
Ma Tao senior management
Li Xiang Yu senior management
Wu Yu Jun Supervisors
Wang Zhi Ming senior management
Lu Shu Huan Core technical personnel
Yi De Wei Director

Cabio Biotech (Wuhan) Co Headlines

No Headlines